Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1105780 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Integrin alpha M (ITGAM) antibody (FITC)
- Antibody type
- Monoclonal
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Green dye
- Isotype
- IgG
- Antibody clone number
- VIM12
- Vial size
- 0.5 mL
- Storage
- Store the antibody undiluted at 2-8°C.
- Handling
- DO NOT FREEZE! This product is photosensitive and should protected from light.
Submitted references Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18).
Granulocyte activation via a binding site near the C-terminal region of complement receptor type 3 alpha-chain (CD11b) potentially involved in intramembrane complex formation with glycosylphosphatidylinositol-anchored Fc gamma RIIIB (CD16) molecules.
Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes.
Thornton BP, Vĕtvicka V, Pitman M, Goldman RC, Ross GD
Journal of immunology (Baltimore, Md. : 1950) 1996 Feb 1;156(3):1235-46
Journal of immunology (Baltimore, Md. : 1950) 1996 Feb 1;156(3):1235-46
Granulocyte activation via a binding site near the C-terminal region of complement receptor type 3 alpha-chain (CD11b) potentially involved in intramembrane complex formation with glycosylphosphatidylinositol-anchored Fc gamma RIIIB (CD16) molecules.
Stöckl J, Majdic O, Pickl WF, Rosenkranz A, Prager E, Gschwantler E, Knapp W
Journal of immunology (Baltimore, Md. : 1950) 1995 May 15;154(10):5452-63
Journal of immunology (Baltimore, Md. : 1950) 1995 May 15;154(10):5452-63
Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes.
Bohuslav J, Horejsí V, Hansmann C, Stöckl J, Weidle UH, Majdic O, Bartke I, Knapp W, Stockinger H
The Journal of experimental medicine 1995 Apr 1;181(4):1381-90
The Journal of experimental medicine 1995 Apr 1;181(4):1381-90
No comments: Submit comment
No validations: Submit validation data